The NIH has awarded $850,000 to Northwell Health’s Feinstein Institutes to advance a noninvasive menstrual blood test for endometriosis, aiming to reduce reliance on surgical diagnosis, according to the institutes.
A peer-reviewed economic analysis challenges the assumption that erythrocyte sedimentation rate and C-reactive protein tests are interchangeable, finding that combined testing reduces misdiagnoses and lowers overall costs.
The FDA has cleared Roche’s cobas c 703 and cobas ISE neo, high-throughput analytical units designed to automate workflows and address staffing and capacity challenges.
Emerging companies from six countries will exhibit enabling technologies at the Society of Laboratory Automation and Screening's annual European conference in Vienna this May.
The FDA has granted a CLIA waiver for FebriDx, enabling its use in over 300,000 U.S. point-of-care settings and potentially reaching 80 million patients annually, according to PHASE Scientific.
